Chemokines Do More Than Direct Traffic
Posted by Brian Volkman on 10/30/2026 to
Literature Highlights
Research from the University of Fribourg reveals that CCL21 does more than direct immune cell traffic, it actively terminates CD8 T cell activation by breaking apart the physical contact between T cells and dendritic cells (DCs) at precisely the right moment.
New Study Confirms Safety of CCL20LD
Posted by Brian Volkman on 10/10/2026 to
Recent Publications
Research from co-founder Dr. Mike Dwinell's lab at the Medical College of Wisconsin advances XLock Biosciences' lead therapeutic candidate.
